|
AstraZeneca Pharma India Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
21713.75 Cr.
|
P/BV
|
31.96
|
Book Value (Rs.)
|
271.74
|
|
52 Week High/Low (Rs.)
|
9211/4800
|
FV/ML
|
2/1
|
P/E(X)
|
134.44
|
|
Bookclosure
|
05/07/2024
|
EPS (Rs.)
|
64.60
|
Div Yield (%)
|
0.28
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 1295.53 | 1002.97 | 805.60 | 813.56 | 831.77 |
| Other Operating Revenues | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Total Operating Revenues | 1295.53 | 1002.97 | 805.60 | 813.56 | 831.81 |
| | | | | | |
| Other Income | 34.80 | 26.10 | 14.76 | 12.84 | 12.99 |
| Total Revenue | 1330.33 | 1029.07 | 820.36 | 826.40 | 844.80 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 129.02 | 84.38 | 89.61 | 97.26 | 70.21 |
| Purchase Of Stock-In Trade | 499.31 | 324.46 | 207.88 | 194.74 | 274.23 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -33.77 | -48.86 | 14.47 | 2.95 | -39.21 |
| Employee Benefit Expenses | 241.45 | 259.10 | 230.21 | 219.54 | 216.70 |
| Finance Costs | 1.20 | 0.63 | 0.95 | 1.09 | 1.14 |
| Depreciation And Amortisation Expenses | 14.94 | 16.26 | 16.95 | 20.13 | 18.58 |
| Other Expenses | 275.07 | 218.77 | 177.25 | 163.60 | 189.18 |
| Total Expenses | 1127.22 | 854.74 | 737.32 | 699.31 | 730.83 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 203.11 | 174.33 | 83.04 | 127.09 | 113.97 |
| | | | | | |
| Exceptional Items | 16.43 | -40.23 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 219.54 | 134.10 | 83.04 | 127.09 | 113.97 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 53.55 | 38.30 | 22.63 | 34.83 | 31.51 |
| Deferred Tax | -0.90 | -3.49 | -1.19 | -1.04 | 10.25 |
| Tax For Earlier Years | 5.38 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Tax Expenses | 58.03 | 34.81 | 21.44 | 33.79 | 41.76 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 161.51 | 99.29 | 61.60 | 93.30 | 72.21 |
| | | | | | |
| Profit/Loss From Continuing Operations | 161.51 | 99.29 | 61.60 | 93.30 | 72.21 |
| | | | | | |
| Profit/Loss For The Period | 161.51 | 99.29 | 61.60 | 93.30 | 72.21 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 64.60 | 39.70 | 24.60 | 37.30 | 28.90 |
| Diluted EPS (Rs.) | 64.60 | 39.70 | 24.60 | 37.30 | 28.90 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 40.00 | 20.00 | 5.00 | 5.00 | 2.50 |
| Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 |
| Equity Dividend Rate (%) | 1200.00 | 800.00 | 500.00 | 100.00 | 50.00 |
